Atlas Oncology Partners Raises $28M Series A to Scale Value-Based Oncology Care Atlas Oncology Partners today announced the closing of its Series A financing. Atlas was founded by Rubicon Founders,…
Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with…
United Natural Foods Shares 2026 Spring and Summer Retail Trends At its 2026 Spring and Summer Selling Show in Orlando, Fla., United Natural Foods, Inc. (NYSE: UNFI) brought more than…
New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option…
1,600+ Pharmacies Using EQUIPP Copilot™ Report Up to 4x Revenue Boost, Close More Care Gaps Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced significant…
AOP Health US, LLC Awarded Pharmaceutical Agreement With Premier, Inc. AOP Health US, LLC has been awarded a Pharmaceutical national group purchasing agreement with Premier, Inc. Effective August 1, 2025,…
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial Coya Therapeutics, Inc a clinical-stage biotechnology company developing biologics…
Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis Evommune, Inc. a clinical-stage biotechnology company developing innovative therapies that target key drivers of…
NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors NextPoint Therapeutics, a clinical-stage biotechnology company developing a new world of precision therapeutics through its…
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1 Takeda today announced that…
Kradle Expands Feline Supplement Portfolio With Kradle Max Full-Spectrum Hemp Calming Tincture for Cats Kradle, a premium pet wellness brand known for its innovative and easy-to-use natural calming solutions for…
RUBAR Acquired by ETi Gıda for $173 Million, Ushering in Next Phase of Global Growth TRUBAR, the fast-growing protein bar brand known for its dessert-inspired flavors and clean ingredients, today…